Chronic lymphocytic leukemia (CLL) with cytogenetics findings, such as complex karyotype and deletions of TP53 or ATM, is associated with adverse clinical outcomes. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.